🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
GIL
$GILD
🔒 US EquitiesGilead Sciences, Inc.
AVG HISTORICAL GAP
+0.20%
MAX GAP RECORD
+4.02%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $GILD
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$GILD
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00)) |
+2.65%
|
| Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE) |
+0.55%
|
| Apr 23, 2026 Earnings Release 2026-04-23 (AFTER CLOSE) |
-1.57%
|
| Feb 10, 2026 Earnings Release 2026-02-10 (AFTER CLOSE) |
+1.13%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE) |
-2.01%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
-0.45%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-1.40%
|
| Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN) |
+0.50%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.8%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (4)
📖 Intelligence Summary
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗